Long Non-coding RNA HULC As a Potential Prognostic Biomarker in Human Cancers: a Meta-analysis

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Feb 16

PMID 28199963

Citations 9

Authors

Yang-Hua Fan

Miao-Jing Wu

Yuan Jiang

Minhua Ye

Shi-Gang Lu

Lei Wu

Xin-Gen Zhu

Affiliations

Soon will be listed here.

Abstract

Since the long non-coding RNA HULC (Highly Upregulated in Liver Cancer) is dysregulated in many cancers, we performed a meta-analysis to determine its prognostic potential in malignant tumors. We searched electronic databases, including PubMed, Medline, OVID, Cochrane Library and Web of Science from inception until August 14, 2016 and identified seven studies with 730 cancer patients for the meta-analysis. We analyzed the hazard ratios (HRs) and 95% confidence intervals (CIs) to determine the relationship between HULC expression and overall survival (OS). We also using RevMan5.3 software to calculate odds ratio (ORs) to assess the association between HULC expression and pathological parameters, including lymph node metastasis (LNM), distant metastasis (DM) and the tumor stage. Our analysis showed that higher HULC expression was associated with OS (HR= 0.50, 95% CI: 0.35-0.70, P <0.00001), LNM (OR=0.20, 95 % CI 0.06-0.64), DM (OR=0.27, 95% CI: 0.13-0.54) and the tumor stage (OR=0.39, 95 % CI 0.25-0.64). These meta-analysis data demonstrate that higher HULC expression can be a useful prognostic biomarker in human cancers.

Citing Articles

LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.

Li D, Wang R, Wu N, Yu Y Aging (Albany NY). 2022; 14(4):1797-1811.

PMID: 35183058 PMC: 8908940. DOI: 10.18632/aging.203903.

Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Lin X, Xiang X, Feng B, Zhou H, Wang T, Chu X Front Oncol. 2021; 11:670838.

PMID: 34249710 PMC: 8267409. DOI: 10.3389/fonc.2021.670838.

Identifying modules of cooperating cancer drivers.

Klein M, Cannataro V, Townsend J, Newman S, Stern D, Zhao H Mol Syst Biol. 2021; 17(3):e9810.

PMID: 33769711 PMC: 7995435. DOI: 10.15252/msb.20209810.

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma.

Sukowati C, Cabral L, Tiribelli C, Pascut D Biomedicines. 2021; 9(1).

PMID: 33477833 PMC: 7832835. DOI: 10.3390/biomedicines9010090.

Co-expression network analysis of lncRNAs and mRNAs in rat liver tissue reveals the complex interactions in response to pathogenic cytotoxicity.

Leng D, Huang C, Lei K, Sun S, Sun B, Zhang X Int J Biol Sci. 2019; 15(11):2296-2307.

PMID: 31595148 PMC: 6775316. DOI: 10.7150/ijbs.33735.

References

Cho J, Lee Y, Sun D, Kim M, Cho K, Nam I . Prognostic impact of lymph node micrometastasis in oral and oropharyngeal squamous cell carcinomas. Head Neck. 2015; 38 Suppl 1:E1777-82. DOI: 10.1002/hed.24314. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Du Z, Fei T, Verhaak R, Su Z, Zhang Y, Brown M . Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol. 2013; 20(7):908-13. PMC: 3702647. DOI: 10.1038/nsmb.2591. View

Panzitt K, Tschernatsch M, Guelly C, Moustafa T, Stradner M, Strohmaier H . Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132(1):330-42. DOI: 10.1053/j.gastro.2006.08.026. View

Peng W, Wu J, Feng J . Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma. Biomed Pharmacother. 2016; 79:188-93. DOI: 10.1016/j.biopha.2016.02.032. View

Gu W, Gao T, Sun Y, Zheng X, Wang J, Ma J . LncRNA expression profile reveals the potential role of lncRNAs in gastric carcinogenesis. Cancer Biomark. 2015; 15(3):249-58. DOI: 10.3233/CBM-150460. View

Yang X, Huang C, Peng C, Hou J, Liu J . Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression. Gene. 2016; 592(1):172-178. DOI: 10.1016/j.gene.2016.08.002. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Peng W, Gao W, Feng J . Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Med Oncol. 2014; 31(12):346. DOI: 10.1007/s12032-014-0346-4. View

10.

Li S, Xu H, Yu Y, He J, Wang Z, Xu Y . LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016; 7(27):42431-42446. PMC: 5173146. DOI: 10.18632/oncotarget.9883. View

11.

Altman D, McShane L, Sauerbrei W, Taube S . Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med. 2012; 9(5):e1001216. PMC: 3362085. DOI: 10.1371/journal.pmed.1001216. View

12.

Uzan V, van Helvoort Lengert A, Boldrini E, Penna V, Scapulatempo-Neto C, Scrideli C . High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients. PLoS One. 2016; 11(6):e0156774. PMC: 4890737. DOI: 10.1371/journal.pone.0156774. View

13.

Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H . A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res. 2015; 35(3):1385-8. View

14.

Loewen G, Jayawickramarajah J, Zhuo Y, Shan B . Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014; 7:90. PMC: 4266198. DOI: 10.1186/s13045-014-0090-4. View

15.

Ma Y, Huang D, Yang F, Tian M, Wang Y, Shen D . Long Noncoding RNA Highly Upregulated in Liver Cancer Regulates the Tumor Necrosis Factor-α-Induced Apoptosis in Human Vascular Endothelial Cells. DNA Cell Biol. 2016; 35(6):296-300. DOI: 10.1089/dna.2015.3203. View

16.

DU Y, Kong G, You X, Zhang S, Zhang T, Gao Y . Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287(31):26302-11. PMC: 3406714. DOI: 10.1074/jbc.M112.342113. View

17.

Qi P, Du X . The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2012; 26(2):155-65. DOI: 10.1038/modpathol.2012.160. View

18.

Guo H, Wu L, Yang Q, Ye M, Zhu X . Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. Gene. 2014; 554(1):114-9. DOI: 10.1016/j.gene.2014.10.038. View

19.

Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jaafari M, Mirzaei H . MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer. 2015; 53:25-32. DOI: 10.1016/j.ejca.2015.10.009. View

20.

Fan Y, Ye M, Wu L, Lv S, Wu M, Xiao B . Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε. Eur Rev Med Pharmacol Sci. 2015; 19(19):3593-604. View